• Facebook
  • Twitter
  • LinkedIn
  • Login
Sentry Data Systems, Inc.
  • Company
    • Expect More with Sentry
    • Senior Leadership Team
    • Mission, Vision and Guiding Principles
    • Employment
    • Security Statement
  • Solutions
    • 340B Solutions
      • Sentinel Hospital Procurement and 340B Compliance
      • Trisis Medication Claim, formerly Claims Manager Plus
      • Sentrex 340B Contract Pharmacy Management
      • Sentrex330 for Clinics
      • Sentrex eRx Eligibility Check
      • Referral Verification System (RVS)
    • Senturion Services
      • Senturion Professional Services
        • Audit Preparation
        • Orphan Drug Opportunity
      • Senturion Support
  • News & Events
  • Resources
  • Contact
  • Blog
  • Search
  • Menu Menu

Senturion professional services – orphan drug opportunity

Optimize 340B program compliance and orphan drug spend

Our Orphan Drug Opportunity supplements our Sentinel® technology capabilities, helping to maintain compliance with 340B Orphan Drug Exclusion requirements, uncover cost-effective ways to obtain orphan drugs, and provide ongoing 340B program oversight and maintenance.

Senturion Orphan Bullet 1 ReduceO - Senturion Professional Services – Orphan Drug Opportunity

Reduce audit risks, meeting 340B program compliance requirements with respect to orphan drug exclusions

Senturion Orphan Bullet 2 VerifyO - Senturion Professional Services – Orphan Drug Opportunity

Verify that our Sentinel Blacklist Tool contains the most up-to-date list of orphan drugs

Senturion Orphan Bullet 3 AdjustO - Senturion Professional Services – Orphan Drug Opportunity

Adjust configurations in the Sentinel Blacklist Tool to meet program requirements

Senturion Orphan Bullet 4 AssessO - Senturion Professional Services – Orphan Drug Opportunity

Assess active manufacturer contracts for orphan drugs and identify opportunities to optimize purchasing

Senturion Orphan Bullet 5 NegotiateO - Senturion Professional Services – Orphan Drug Opportunity

Negotiate/renegotiate external contracts and agreements with orphan drug manufacturers as necessary

Senturion Orphan Bullet 6 ProvideO - Senturion Professional Services – Orphan Drug Opportunity

Provide quarterly program review, adjusting orphan drug NDCs in the Sentinel Blacklist Tool and reviewing contracts with manufacturers

Common pain point

Maintaining compliance when it comes to 340B Orphan Drug Exclusion requirements is a challenge that not every system can meet — and negotiating discounts on orphan drugs can often go overlooked.

Our Orphan Drug Opportunity service helps you verify that you have the most up-to-date list of orphan drugs on hand and that they are excluded from 340B. We will also help you evaluate and negotiate existing contracts with pharma manufacturers to optimize orphan drug prices.

Interested in knowing more? Complete the form below to request a free needs assessment and see how together we can optimize your orphan drug compliance and pricing.

Sentry Data Systems logo
  • sentry data systems, inc., a Craneware company
  • 800 Fairway Drive, Suite 400
  • Deerfield Beach, FL 33441
  • 800.411.4566 phone
  • Security and Privacy
  • Site Map
© 2023 Sentry Data Systems, Inc. All rights reserved. No unauthorized reproduction.
      
X
Scroll to top